FDA Inspection 1020411 — Crestview Pharma, LLC
The FDA completed an inspection of Crestview Pharma, LLC on July 13, 2017 in Aiken, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 13, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Aiken, SC (United States)